|
⚲
|
| Keyboard |
| CK Life Sciences Intl Holdings Inc
✚
|
|
|---|---|
| CIK # | 0001297567 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001297567] | |
| 4 | [0001297567] | |
| SC 13D | [0001297567] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| CK Life Sciences Intl Holdings Inc | Transcode Therapeutics Inc | [2025-10-16] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Conjoint Inc | |
| CK Life Sciences Intl Holdings Inc | |
| Dogwood Therapeutics Inc | |
| Sealbond Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Dogwood Therapeutics Inc DWTX
Common Stock
|
2025-11-21 | Conversion | 2,842,638 | ||
|
Dogwood Therapeutics Inc DWTX
Common Stock
|
2025-11-21 | Conversion | 21,610,950 | ||
|
Dogwood Therapeutics Inc DWTX
Series A-1 Preferred Stock · derivative
|
2025-11-21 | Conversion | 284.26 | $0.00 | |
|
Dogwood Therapeutics Inc DWTX
Series A Preferred Stock · derivative
|
2025-11-21 | Conversion | 2,161.10 | $0.00 | |
|
Dogwood Therapeutics Inc DWTX
Series A-1 Preferred Stock · derivative
|
2025-03-12 | Grant | 284.26 | $7.01 | 1,993 |